2BBBullish & Bearish
Health Care

Xeris Biopharma Holdings, Inc. (XERS) Stock Score & Signals

Xeris Biopharma Holdings, Inc. (XERS) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 61 out of 100.

2BB score and signals

Xeris Biopharma Holdings, Inc.’s current 2BB score is 61 out of 100, built from the signal categories below.

SignalScoreReading
Activity74High
Momentum85Strongly Improving
Financial strength60Normal
Quality92Very Strong

Company facts

HeadquartersChicago, Illinois, United States
Founded2005
Employees435
52-week range$5.25 – $11.33

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-03-01—0.0408—$113.53M
2026-11-05—0.0265—$103.38M
2026-08-06—0.0034—$92.03M
2026-05-06—-0.0051—$82.29M